John V. Kiluk

2.1k total citations
74 papers, 1.3k citations indexed

About

John V. Kiluk is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, John V. Kiluk has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cancer Research, 38 papers in Pathology and Forensic Medicine and 28 papers in Surgery. Recurrent topics in John V. Kiluk's work include Breast Cancer Treatment Studies (47 papers), Breast Lesions and Carcinomas (38 papers) and Breast Implant and Reconstruction (20 papers). John V. Kiluk is often cited by papers focused on Breast Cancer Treatment Studies (47 papers), Breast Lesions and Carcinomas (38 papers) and Breast Implant and Reconstruction (20 papers). John V. Kiluk collaborates with scholars based in United States, Germany and Iran. John V. Kiluk's co-authors include Christine Laronga, Nazanin Khakpour, Charles E. Cox, Marie Catherine Lee, Géza Ács, Tammi Meade, Nicole N. Esposito, Loretta Loftus, Elisabeth Dupont and Susan Hoover and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

John V. Kiluk

69 papers receiving 1.3k citations

Peers

John V. Kiluk
Shelley Hwang United States
David R. Brenin United States
Fiona MacNeill United Kingdom
Kathie‐Ann Joseph United States
Jennifer L. Gnerlich United States
George N. Peters United States
Katherine N. Tran United States
John V. Kiluk
Citations per year, relative to John V. Kiluk John V. Kiluk (= 1×) peers Stephanie M. Wong

Countries citing papers authored by John V. Kiluk

Since Specialization
Citations

This map shows the geographic impact of John V. Kiluk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John V. Kiluk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John V. Kiluk more than expected).

Fields of papers citing papers by John V. Kiluk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John V. Kiluk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John V. Kiluk. The network helps show where John V. Kiluk may publish in the future.

Co-authorship network of co-authors of John V. Kiluk

This figure shows the co-authorship network connecting the top 25 collaborators of John V. Kiluk. A scholar is included among the top collaborators of John V. Kiluk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John V. Kiluk. John V. Kiluk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Hyo S., Amy L. Aldrich, Saurabh Garg, et al.. (2024). Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer. JAMA Oncology. 11(2). 119–119. 1 indexed citations
2.
Lengacher, Cecile A., Richard R. Reich, Anh Nguyen, et al.. (2024). Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial. Journal of Integrative and Complementary Medicine. 31(1). 75–91. 1 indexed citations
3.
Whiting, Junmin, Weihong Sun, Brian J. Czerniecki, et al.. (2024). Retrieval of the Clipped Axillary Lymph Node and Its Impact on Treatment Decisions. Cancers. 16(17). 3001–3001.
4.
Soliman, Hatem, Hyo S. Han, Blaise Mooney, et al.. (2023). Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial. Nature Medicine. 29(2). 450–457. 50 indexed citations
6.
Sun, Weihong, Junmin Whiting, Melissa Anne Mallory, et al.. (2023). Factors Predictive of Positive Lymph Nodes for Breast Cancer. Current Oncology. 30(12). 10351–10362. 8 indexed citations
7.
Whiting, Junmin, Melissa Anne Mallory, Susan Hoover, et al.. (2022). Effect of Microporous Polysaccharide Particles in Patients Undergoing Mastectomy. Clinical Breast Cancer. 22(8). e922–e927. 2 indexed citations
8.
Sun, James, Junjie Ma, Weihong Sun, et al.. (2021). Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia. Cancer Medicine. 10(21). 7665–7672. 13 indexed citations
9.
Parikh, Puja B., Shannon Falcon, Marilin Rosa, et al.. (2021). Adenomyoepithelioma of the breast: Case series and literature review. Clinical Imaging. 75. 157–164. 14 indexed citations
10.
Sun, James, Danielle Henry, Michael J. Carr, et al.. (2020). Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization. Clinical Breast Cancer. 21(3). e189–e193. 26 indexed citations
11.
Kis, Béla, et al.. (2019). High‐output chyle leak after breast‐conserving surgery and sentinel lymph node biopsy. The Breast Journal. 26(3). 514–516. 5 indexed citations
12.
Burke, Erin E., Christine Laronga, Weihong Sun, et al.. (2019). Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants. Clinical Breast Cancer. 20(1). e14–e19. 4 indexed citations
13.
Ackerman, Robert S., et al.. (2018). Enhanced REVENUE After Surgery? A Cost‐Standardized Enhanced Recovery Pathway for Mastectomy Decreases Length of Stay. World Journal of Surgery. 43(3). 839–845. 20 indexed citations
14.
Mooney, Blaise, Hui‐Yi Lin, Xiuhua Zhao, et al.. (2017). 2-D and 3-D Ultrasound for Tumor Volume Analysis: A Prospective Study. Ultrasound in Medicine & Biology. 43(4). 775–781. 1 indexed citations
15.
Ács, Géza, Nicole N. Esposito, John V. Kiluk, Loretta Loftus, & Christine Laronga. (2011). A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas. Modern Pathology. 25(4). 556–566. 53 indexed citations
16.
Lee, M. Catherine, Alec Chau, Gang Han, et al.. (2010). Consequences of Axillary Ultrasound in Patients with T2 or Greater Invasive Breast Cancers. Annals of Surgical Oncology. 18(1). 72–77. 39 indexed citations
17.
Kaur, Paramjeet, John V. Kiluk, Tammi Meade, et al.. (2010). Sentinel Lymph Node Biopsy in Patients with Previous Ipsilateral Complete Axillary Lymph Node Dissection. Annals of Surgical Oncology. 18(3). 727–732. 26 indexed citations
18.
Kiluk, John V., Tammi Meade, Michael P. Meyers, et al.. (2008). Pregnancy-Associated Breast Cancer Patients Can Safely Undergo Lymphatic Mapping. The Breast Journal. 14(3). 250–254. 59 indexed citations
19.
Kiluk, John V., Alfredo A. Santillan, Paramjeet Kaur, et al.. (2008). Feasibility of Sentinel Lymph Node Biopsy Through an Inframammary Incision for a Nipple-Sparing Mastectomy. Annals of Surgical Oncology. 15(12). 3402–3406. 13 indexed citations
20.
Cox, Charles E., John V. Kiluk, Adam I. Riker, et al.. (2007). Significance of Sentinel Lymph Node Micrometastases in Human Breast Cancer. Journal of the American College of Surgeons. 206(2). 261–268. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026